Vitality of Indianapolis

BioCrossroads Drives Collaboration and Growth in Indiana’s Life Sciences Sector

Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Health

How We’re Addressing Indiana’s Unmet Need for Opioid Addiction Treatment

Claire Fiddian-Green is the President and CEO of the Richard M. Fairbanks Foundation. Opioid addiction is taking an undeniable toll on Hoosiers struggling with addiction, their families, and Indiana employers and communities. In an ideal world, we could keep people from becoming addicted to prescription pain medicine or using heroin in the first place through […]

READ MORE
Health

Why Lowering Nicotine in Cigarettes Could Help Save Hoosier Lives

Reducing the amount of nicotine in cigarettes may lead some current smokers to smoke more – at least in the short term. But there’s also evidence that reducing nicotine in cigarettes can help reduce smoking.

READ MORE